A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Tissue matrix scaffold is an advanced tissue-mimicry 3D culture system for biomedical research and drug screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer and stromal cells are cultured in a compartmental fashion that induces the expression of intracellular and extracellular biomarkers of breast cancer cells, thus con fi rming correct tumor growth and proliferation.”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This TMS therefore mimics the structure of the mammary tissue while providing a simple-to-use tool for screening speci fi c tumor biomarkers [35].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“A tissue matrix scaffold (TMS) using native ECM has been developed to overcome cell culture methods that do not mimic the biophysical/biochemical properties of the ECM [35].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“This in vitro model consists of a multilayered tissue culture platform prepared from decellularized mouse mammary tissue.”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels for Tissue Engineering
Lee, K. Y., & Mooney, D. J. (2001) · Chemical Reviews · doi:10.1021/cr000108x · Cited by 5,277
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
An overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“1D, bottom right), where rich adipose and less connective tissues are present (42).”
BackgroundPrinting three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
Basement membrane complexes with biological activity
Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., & Martin, G. R. (1986) · Biochemistry · doi:10.1021/bi00350a005 · Cited by 1,502 · cited 1×
“Because the tumor and normal tissue ECM are different, and the ECMcomponents are critical for the expression of specific cell surface receptors (14), the tumor-derived laminin- and collagen IV–rich hydrogelmay not be appropriate for certain cell signaling andmolecular mechanistic studies that involve culturing normal…”
BackgroundCarcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144
Research works printed but not linked: 1
- M. V. Patrone, J. L. Hubbs, J. E. Bailey, L. B. Marks, How long have I had my cancer, doctor? Estimating tumor age via Collins’ law. Oncology (Williston Park) 25, 38–43 (2011).
Cited by
Items 101–154 of 154
Hao, J., Yu, X., Tang, K., Ma, X., Lu, H., & Wu, C. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.016 · Cited by 10
Radziwon, A., Bhangu, S. K., Fernandes, S., Cortez‐Jugo, C., Rose, R. D., Dyett, B., Wojnilowicz, M., Lázničková, P., Frič, J., Forte, G., et al. (2022) · Nanoscale · doi:10.1039/d1nr08429a · Cited by 9
Lactate Oxidase Disrupts Lactate-Activated RAS and PI3K Oncogenic Signaling
Keller, C. R., Martinez, S. R., Keltz, A., Chen, M. M., & Li, W. (2024) · Cancers · doi:10.3390/cancers16162817 · Cited by 10
Self-citationGuerrero‐López, P., Alamán‐Díez, P., Hernández-Hatibi, S., Balsas, P., & Garcia-Aznar, J. M. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115836 · Cited by 9
Cha, J., & Kim, P. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.018 · Cited by 8
Dynamic Hydrogels in Breast Tumor Models
Rijal, G., & Park, I.-W. (2025) · Gels · doi:10.3390/gels11110855 · Cited by 8
“…proliferation, and epithelial branching [43,44]. dECM, composed of fibrillar proteins like collagens and elastin, and glycoproteins such as laminin and fibronectin, has been recognized as a biologically relevant scaffold that supports cell signaling, adhesion, and growth factor interactions [45].”
Self-citationSivakumar, S., Schmid, R., Wieland, A., Strissel, P. L., Strick, R., Fischer, L., Thievessen, I., Kataev, E. Y., Arkudas, A., Horch, R. E., et al. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202101808 · Cited by 7
Asporin increases the extracellular matrix cross-links and inhibits the cancer cell migration
Hernandez, K., Nguyen, C. H., & Rijal, G. (2025) · Tumor Biology · doi:10.1177/10104283241313441 · Cited by 7
“9,18 The ECM with a more fi brillar network of collagen, as seen in a normal tissue or the inner core of solid tumor tissue, inhibits the metastasis whereas ECM with stiff collagen, as seen in the outer core of TNBC, enhances the metastasis.”
InfluentialSelf-citationDecellularized diseased tissues: current state‐of‐the‐art and future directions
Li, X., Shan, J., Chen, X., Cui, H., Wen, G., & Yu, Y. (2023) · MedComm · doi:10.1002/mco2.399 · Cited by 8
Oct4 controls basement membrane development during human embryogenesis
Rosner, M., & Hengstschläger, M. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.007 · Cited by 6
Tachibana, T., Isoyama, G., Yoshii, Y., Hihara, F., Igarashi, C., Tsuji, A. B., Higashi, T., & Taguchi, M. (2021) · Applied Sciences · doi:10.3390/app11157031 · Cited by 6
Trends in biomaterials for three-dimensional cancer modeling
Caballero, D., Reis, R. L., & Kundu, S. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00001-0 · Cited by 6
Systems approaches to uncovering the contribution of environment-mediated drug resistance
Creixell, M., Kim, H., Mohammadi, F., Peyton, S. R., & Meyer, A. S. (2022) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2022.101005 · Cited by 6
Personalized Drug Screening for Functional Tumor Profiling
El‐Khoury, V., Michel, T., Kim, H., & Kwon, Y. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009037877 · Cited by 5
Degradable Biocompatible Porous Microtube Scaffold for Extended Donor Cell Survival and Activity
Nguyen, H. H., Chen, C., Czosseck, A., Chen, M. M., George, T. A., & Lundy, D. J. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00899 · Cited by 5
Abdollahzadeh, H., Amoabediny, G., Haghiralsadat, F., Rahimi, F., & Adibfar, A. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230501202946 · Cited by 4
Spheroids formation in large drops suspended in superhydrophobic paper cones
Mohapatra, O., Gopu, M., Ashraf, R., George, J. E., Patil, S., Mukherjee, R., Kumar, S., & Mampallil, D. (2024) · Biomicrofluidics · doi:10.1063/5.0197807 · Cited by 4
Extracellular Matrix Isolation: Sources and Methods
Mendibil, U., Ruiz-Hernández, R., Arnáiz, B., Khatami, N., & Abarrategi, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-92090-6_7-1 · Cited by 6
Rijal, G. (2021) · Bioengineering · doi:10.3390/bioengineering8110163 · Cited by 4
“After implantation, it forms a xenografted tumor in an animal tissue within a certain period, depending on the type of cancer cell and hydrogel or scaffold used [4,7,16,17].”
BackgroundInfluentialSelf-citationDomingues, M. F., Carreira, M. C., Santos, M., Pacheco, D. P., Ferreira, F. C., Sanjuan‐Alberte, P., & Silva, J. C. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503633 · Cited by 7
“…tumor-derived dECM in these systems has been shown to enhance the expression of histological hallmarks associated with cancer progression, namely an invasive morphology and enhanced chemoresistance, making it particularly relevant for replicating the OS behavior observed in clinical settings [73].”
Why 3D in vitro cancer models are the future of cancer research?
Petrić, T., & Sabol, M. (2023) · Periodicum Biologorum · doi:10.18054/pb.v124i3-4.24697 · Cited by 3
“To summarize, scaffolds provide an inexpensive and easily analyzable platform which has tunable and instructive properties that can recapitulate relevant biochemical and structural cues (91) , offering a proper ECM-mimicking environment for culturing cells.”
InfluentialSetiawati, A., Kencana, N. B. W., Putra, H. S. D., Kencana, M. V. S. A., Ajiteru, O., Yoga, I. M. B. K., Fatimah, N., & Hermawan, A. (2025) · Macromolecular Research · doi:10.1007/s13233-025-00405-7 · Cited by 5
Cui, X., Liu, H., Liu, Y., Yu, Z., Wang, D., Wei, W., & Wang, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144469 · Cited by 7
Benavides, O. R., VandenHeuvel, S. N., Roy, S., Goggans, B., Holla, S., Rajavel, V., Duran, J., Nash, L. L., Alge, D. L., Walsh, A. J., et al. (2025) · Biomaterials Science · doi:10.1039/d5bm00630a · Cited by 3
Oh, E., Kim, H. G., Choi, M.-H., Lee, J., Kim, S. J., Kwak, J.-Y., & Park, H. J. (2021) · Cancers · doi:10.3390/cancers13143550 · Cited by 4
“Most currently available porous scaffolds are synthesized from polymers such as polycaprolactone and poly (lactic acid-glycolic acid) acid and are generally used for tissue-engineering research, although their use for implantation of synthetic polymer-based scaffolds of 3D cell cultures is increasing [31].”
BackgroundInfluentialIngavle, G. C., & Das, M. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00484 · Cited by 3
Recent advances in tumors-on-chips
Dogan, E., Salemizadehparizi, F., Çeçen, B., & Miri, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85671-3.00006-3 · Cited by 4
Microsphere‐Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models
Wang, W., Zhang, L., O'Dell, R., Yin, Z., Yu, D., Chen, H., Liu, J., & Wang, H. (2023) · Small · doi:10.1002/smll.202307365 · Cited by 3
Tayfur, S. M., Hamid, Z. A. A., Azman, D. K. M., & Bustami, Y. (2026) · Journal of Polymers and the Environment · doi:10.1007/s10924-026-03851-1 · Cited by 2
“These biomimetic attributes enhance drug screening efficacy by replicating key in vivo barri - ers which include physiological drug penetration kinetics and ECM-mediated survival signalling [111, 112].”
Liu, X., Ren, Y., Fu, S., Jiao, Y., Chen, X., Wang, F., Wang, L., Hu, M., & Li, C. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241299941 · Cited by 2
“72 In addition, the IC50 value of 3D MCF-7 spheroids cultured in fibrin was found to be 13 times higher than that of the 2D culture.”
Al-Ruwishan, A., Amer, B., Salem, A., Abdi, A., Chimpandu, N., Esa, A., Melemenis, A., Saleem, M. Z., Mathew, R., & Gamallat, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080492 · Cited by 1
“Additionally, directly engineering microenvironmental niches has shown promise in replicating the complex interactions that occur within the human body [38,69,70], further enhancing the relevance of in vitro models [67,68].”
BackgroundKawamae, R., Takata, A., Takemura, K., & Kurashina, Y. (2026) · Lab on a Chip · doi:10.1039/d5lc00731c · Cited by 1
Fabrication of a Tailored, Hybrid Extracellular Matrix Composite
Setiawati, A., Jeong, S., Brilian, A. I., Lee, S., Shim, J., Jung, K., & Shin, K. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200106 · Cited by 3
Advanced 3D In Vitro Models to Recapitulate the Breast Tumor Microenvironment
Bağcı, G., Ximenes-Carballo, C., Pérez‐Amodio, S., Castaño, Ó., Engel, E., & Blanco‐Fernandez, B. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_56 · Cited by 3
Decellularized Matrix Hydrogels for In Vitro Disease Modeling
Ferreira, L. P., Monteiro, M. V., Gaspar, V. M., & Mano, J. F. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781839161124-00626 · Cited by 2
Functional and eco-friendly polymers in medical and biomedical applications
Palencia, M., Lerma, T. A., Garcés, V., Mora, M. A., Martínez, J. M., & Palencia, S. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821842-6.00007-5 · Cited by 2
Tissue-Derived Decellularized Materials for Biomedical Applications
Magno, V., & Werner, C. (2023) · Springer eBooks · doi:10.1007/978-3-030-92090-6_42-1 · Cited by 1
In vitro and in vivo technologies: an up to date overview in tissue engineering
Popescu, R. C., Andronescu, E., & Grumezescu, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816909-4.00015-4
King, C. T. (2019) · Louisiana State University · doi:10.31390/gradschool_theses.5039
Three-dimensional Hyaluronan-based Hydrogels Designed for Breast Cancer Spheroid Formation
Baker, A. E. G. (2019) · TSpace (University of Toronto)
Monterosso, M. E. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.236375
Sefidgar, E., & Akbari-Birgani, S. (2022) · Cell & Tissue Journal · doi:10.52547/jct.13.2.121
Mimicking Chemical Features of the Tumor Microenvironment
Jayaprakash, S. R., Patra, I. P., Bist, S., & Pradhan, S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00097
Exploration of Tissue-Engineered Systems for Cancer Research
Panigrahi, A., Mythreyi, R., Basalingappa, K. M., Gopenath, T. S., & Karthikeyan, M. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_3
Progress of the Study on Type III Collagen in Breast Cancer
刘, 潇. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441294
Tissue-Derived Decellularized Materials for Biomedical Applications
Magno, V., & Werner, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-56363-8_42
Extracellular Matrix Isolation: Sources and Methods
Mendibil, U., Ruiz-Hernández, R., Arnáiz, B., Khatami, N., & Abarrategi, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-56363-8_7
Additive manufacturing and criteria to fabricate bioinks
Iqubal, M. K., Shaikh, R., Dongala, B. P., Pansare, S. J., Thota, S. K., Charoo, N. A., Mohamed, E. M., Khan, M. A., & Rahman, Z. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27378-0.00011-8
Research Progress on Maintaining the Stability of Organoid Culture
夏, 雪. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592554
Özüdoğru, E., Kurt, T., & Arslan, Y. E. (2025) · Biomedical Materials · doi:10.1088/1748-605x/ae187d · Cited by 1
“Nevertheless, cancer models generated with the ECM of healthy tissues [13, 14] or synthetic polymers [15, 16] and cancer cells (2D) [17] are insufficient to mimic native tumor tissue.”
Developing Mammary Gland Models for Biomedical Applications
Zhao, J., Lin, X., Zhang, H., & ZHAO, Y. (2026) · Research · doi:10.34133/research.1240
“…scaffolds, decellularized hydrogels demonstrate remarkable advantages in both performance and applicability, notably including tunable pore size, tailorable mechanical properties, and injectability, which make them highly suitable for advanced applications such as bioprinting [ 75 , 80 , 81 ].”
Liu, X., Xiao, Y., Zhou, Y., Teng, Y., Zou, J., Zhou, Y., Fan, X., Zhao, J., Qiu, J., Tang, L., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00196 · Cited by 2
Smart hydrogel-based anticancer strategies for postoperative osteosarcoma management
Diwan, H., Behera, S. S., & Murab, S. (2026) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2026.1906677
Zhang, K. L., Hamzah, R. N., Chu, J., Duazo, M., Kaldas, S., Griffin, R., & Alghazali, K. M. (2026) · Research Square · doi:10.21203/rs.3.rs-10789864/v1
Metadata
- Authors
- Rijal, G., & Li, W.
- Affiliations
- Washington State University Spokane (US)
- Corresponding author
- Li, Weimin
- Venue
- Science Advances
- Published
- 2017-09
- Volume
- 3
- Issue
- 9
- Pages
- e1700764-e1700764
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC5597314
- OpenAlex
- W2754118249
- Cited by
- 154
- References
- 58
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 22 · 2023: 18 · 2022: 24 · 2021: 27 · 2020: 24 · 2019: 10 · 2018: 8 · 2017: 1
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Washington State University (award329921, Start-up fund)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- tumor modeling, anticancer drug screening, 3D cell culture, extracellular matrix, tumor microenvironment, tumor invasion, hydrogel scaffolds, preclinical drug testing
- MeSH terms
- Animals, Antineoplastic Agents, Cell Survival, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Extracellular Matrix, Humans, Stromal Cells, Coculture Techniques, Hydrogels, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tissue Culture Techniques, Cell Proliferation, Mice, Tissue Scaffolds, Workflow
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.